ICCTO 2012 : International Conference on Clinical Trials in Oncology

Madrid, Spain
March 28-29, 2012

The XXXIII. International Conference on Clinical Trials in Oncology aims to bring together academic scientists, leading engineers, industry researchers and scholar students to exchange and share their experiences and research results about all aspects of Clinical Trials in Oncology, and discuss the practical challenges encountered and the solutions adopted.

ONLINE PAPER SUBMISSION
Authors are invited to submit full-length papers (maximum twelve pages), including figures, tables and references, of novel research material. Please click here to submit your full-lenght conference papers!

CONFERENCE PROCEEDINGS
The International Refereed Conference Proceedings will be blind peer reviewed by three competent reviewers and indexed by Excellence in Research for Australia (ERA), Google Scholar, Scopus, Compendex, Thomson Reuters, WorldCat, EBSCO, GALE,  Embase, Reaxys, Engineering Village / Engineering Index (EI), Library of Congress, British Library, Electronic Journals Library will be internationally distributed both in Electronic CD-ROM Format  and  Proceedings Book.

CONFERENCE REGISTRATION

Early Conference Registration Fees		Late Conference Registration Fees
Keynote and Invited Speakers	Free of Charge	Keynote and Invited Speakers	Free of Charge
Non-Student Author Delegates	450 EURO	Non-Student Author Delegates	500 EURO
Student Author Delegates	350 EURO	Student Author Delegates	400 EURO
Conference Listener Delegates	250 EURO	Conference Listener Delegates	300 EURO
Online Author Registration Form		Online Listener Registration Form

SPECIAL JOURNAL ISSUES

ICCTO 2012 has teamed up with the International Journal of Medical and Biological Sciences for publishing a Special Journal Issue on Advances in Clinical Trials in Oncology. All submitted papers will have opportunities for consideration for this Special Journal Issue. The selection will be carried out during the review process as well as at the conference presentation stage. Submitted papers must not be under consideration by any other journal or publication. The final decision will be made based on peer review reports by the guest editors and the Editor-in-Chief jointly.